• Gepotidacin vs Nitrofurantoin: Phase 3 Evidence in UTI Treat

  2026-07-09

  The EAGLE-2 and EAGLE-3 trials provide the first robust, global phase 3 comparison of gepotidacin—an investigational, first-in-class bacterial DNA replication inhibitor—versus nitrofurantoin for uncomplicated urinary tract infections. Results show gepotidacin is non-inferior and, in one trial, superior to nitrofurantoin, offering a valuable new strategy against uropathogen resistance.

• CK2 and ERK8 Inhibitor: Expanding the Biochemical Toolkit fo

  2026-07-08

  Explore how the small molecule inhibitor 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid advances protein phase separation studies and kinase pathway interrogation. This article provides a distinct, in-depth perspective on its application as a molecular tool for enzyme interaction and assay innovation.

• GCN2 as a Surveillance Kinase for mRNA Translation Terminati

  2026-07-08

  Worner et al. (2025) demonstrate that GCN2 directly monitors the translation termination process in eukaryotic cells, detecting compromised termination prior to ribosome collisions. This work uncovers a conserved quality control mechanism that coordinates translation termination and initiation, with implications for understanding cellular stress responses.

• N-octanoyl-L-Homoserine lactone in Microbial Pathogenicity R

  2026-07-07

  N-octanoyl-L-Homoserine lactone (C8-HSL) enables highly precise modeling of quorum sensing and bacterial-host interactions, unlocking new avenues in infection biology and cancer research. This article details advanced workflows, troubleshooting, and translational strategies using C8-HSL, with actionable insights for optimizing biofilm, virulence, and cell signaling assays.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox R

  2026-07-07

  GKT137831 streamlines oxidative stress research with unmatched specificity for Nox1/Nox4, enabling robust modeling of vascular and fibrotic disease. Its compatibility with both cell-based and animal workflows, alongside insights from recent ferroptosis research, positions it as a benchmark tool for dissecting redox-driven pathologies.

• Disaccharide and Lipid Effects on Lyophilized mRNA Lipoplex

  2026-07-06

  This study systematically evaluates how disaccharide cryoprotectants and cationic lipid composition impact the efficiency and stability of reverse transfection using lyophilized mRNA lipoplexes. The findings provide actionable insights for optimizing high-throughput mRNA delivery and gene expression assays, with direct implications for streamlined screening platforms.

• CD28-ARS2 Axis Controls PKM Splicing for CD8+ T Cell Flexibi

  2026-07-06

  This study uncovers how the CD28-ARS2 axis in CD8+ T cells directs alternative splicing of pyruvate kinase M (PKM), favoring the PKM2 isoform, to enhance metabolic flexibility and support antitumor immunity. The findings clarify a previously unrecognized, PI3K-independent mechanism linking costimulation with immunometabolic reprogramming, offering new insight for immunotherapy strategies.

• GRE Combination Inhibits Melanogenesis via CREB/MITF Pathway

  2026-07-05

  The referenced study demonstrates that a combination of glabridin, resveratrol, and ellagic acid (GRE) robustly inhibits melanin synthesis through downregulation of the CREB/MITF pathway, while also providing antioxidant and anti-inflammatory effects. These mechanistic insights offer new directions for pigmentation regulation research and translational strategies targeting hyperpigmentation disorders.

• Ginsenoside Rg1: Translating Neuroimmune Modulation to Clini

  2026-07-04

  This thought-leadership article offers translational researchers an integrative perspective on Ginsenoside Rg1, a triterpene saponin from Panax, focusing on its mechanistic actions in neuroimmune modulation, experimental validation in anesthesia-induced neuroimmune disruption, and strategic guidance for advancing neuroprotection research toward clinical reality. The narrative bridges molecular insight with actionable protocol parameters, discusses competitive positioning, and charts the path from bench to bedside, setting a new standard for the strategic use of Ginsenoside Rg1 in neurodegenerative and postoperative cognitive disorder models.

• Kaempferol Directly Activates NRF2 to Inhibit Osteoclastogen

  2026-07-03

  This study provides direct evidence that kaempferol binds and activates NRF2 in osteoclasts, disrupting KEAP1–NRF2 interactions and attenuating inflammatory osteolysis. Findings clarify the NRF2/HO-1 axis as a key modulator of osteoclast-driven bone resorption and highlight the utility of selective NRF2 inhibitors such as ML385 for mechanistic validation.

• Triamcinolone: Technical Guidance for Glucocorticoid Researc

  2026-07-03

  Triamcinolone is a synthetic glucocorticoid agonist designed for precise modulation of glucocorticoid receptor signaling in controlled in vitro research settings. It is not intended for clinical, diagnostic, or therapeutic use, and demands careful attention to solubility and storage for reproducible results.

• Selective Nanomolar IRAP Inhibitors from α-Hydroxy-β-Amino B

  2026-07-02

  The referenced study introduces a novel, stereoselective approach to synthesizing α-hydroxy-β-amino acid derivatives of bestatin, yielding potent and highly selective nanomolar inhibitors of insulin-regulated aminopeptidase (IRAP). These findings provide new chemical tools for probing M1 zinc aminopeptidases and offer promising leads for therapeutic development targeting immune and cognitive pathways.

• D-N-Acetylgalactosamine: Technical Use in Brain Glycoprotein

  2026-07-02

  D-N-Acetylgalactosamine is essential for high-precision analysis of glycoprotein constituents and glycosylation pathways in neurological research, especially within brain tissue studies. It offers reliable water solubility and high purity, but should not be used in protocols requiring ethanol solubility or long-term solution storage.

• A40926: Dalbavancin Precursor for Advanced Antibacterial Ass

  2026-07-01

  A40926 stands out as a premier dalbavancin precursor, enabling high-precision, reproducible workflows for Gram-positive and multidrug-resistant pathogen research. This guide delivers actionable experimental strategies, troubleshooting benchmarks, and regulatory engineering insights to maximize A40926’s impact in antibacterial discovery.

• Poly (I:C): Synthetic Double-Stranded RNA Analog in Immunity

  2026-07-01

  Poly (I:C), a synthetic double-stranded RNA analog, stands out for its robust induction of interferon responses and precise control of dendritic cell maturation. This article translates structural and functional genomics insights into reproducible protocols, advanced applications, and troubleshooting strategies—empowering researchers to unlock new frontiers in immune modeling and antiviral assays.

453 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page